Immunocore (NASDAQ:IMCR – Get Free Report) was upgraded by equities research analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of Immunocore in a research report on Friday, July 17th. Cantor Fitzgerald reiterated an “overweight” rating on shares of Immunocore in a research report on Monday, July 13th. Finally, Wall Street Zen downgraded shares of Immunocore from a “buy” rating to a “hold” rating in a report on Tuesday, July 28th. Get Immunocore alerts:View Our Latest Research Report on ImmunocoreImmunocore Stock PerformanceNASDAQ:IMCR opened at $34.50 on Wednesday.